BACKGROUND Diabetes mellitus (DM) is a global epidemic with significant morbidity. Diabetic retinopathy (DR) is a specific microvascular complication of DM which affects around 1 in 3 persons with DM. Epidemiological studies and clinical trials have shown that optimal control of blood glucose can reduce the risk of developing retinopathy and slow its progression. Diabetic Macular Oedema (DME) is a major cause for visual impairment. The aim of the study is to evaluate correlation between glycaemic indices and central foveal thickness in patients with diabetic retinopathy with macular oedema. METHODS Fifty eyes of fifty patients with moderate non-proliferative diabetic retinopathy (NPDR) were enrolled in the study. All patients underwent complete ophthalmic examinations including OCT measurements of central macular thickness (CMT). Patients also underwent FBS, PPBS and glycosylated haemoglobin level tests. The correlation between the CMT and glycaemic indices was noted and evaluated. RESULTS Out of the fifty patients, males accounted for 32 and females 18. The mean age of patients with DME was 57.31 ± 6.32 and patients without DME was 60.60 ± 4.32 (range, 40-70 years). The duration of the study was 8 months. The mean value of HbA1c was 9.07 ± 2.01 in patients with DME and without DME it was 5.58 ± 0.34 (range, 5.2-14.8). The mean central retinal thickness was 409.66 ± 127.18 μm in patients with DME and 205.13 ± 7.94 in patients without DME (range, 186-812 μm). Univariate Analysis revealed that the DME diagnosed by OCT in diabetes was not statistically significant with age (p value-0.073). Whereas it was statistically significant with HbA1c (p value-0.0001), Fasting blood sugar (p value-0.0001), post prandial blood sugar (p value-0.0001). The HbA1c level (>7%) showed a significant (p value-0.001) and positive association with macular thickness in OCT. CONCLUSIONS In patients with HbA1c of above 7% had an increased chance of macular thickness (DME) as measured by OCT, is statistically significant and in patients with poor metabolic control (FBS, PPBS) is associated with macular oedema. Good sugar control decreased the risk of diabetic macular oedema.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.